×
About 94,153 results

ALLMedicine™ Prostate Cancer Center

Research & Reviews  31,275 results

Contributions of social factors to disparities in prostate cancer risk profiles among B...
https://doi.org/10.1158/1055-9965.EPI-21-0697
Cancer Epidemiology, Biomarkers & Prevention : a Publicat... Press DJ, Shariff-Marco S et. al.

Dec 3rd, 2021 - Black men are more likely than Non-Hispanic White (NHW) men to be diagnosed with high-risk prostate cancer (PCa). We examined the extent to which social factors were associated with differences in PCa risk profiles between Black men and NHW men (u...

Instagram and prostate cancer: using validated instruments to assess the quality of inf...
https://doi.org/10.1038/s41391-021-00473-7 10.1007/s00345-018-2254-2 10.1016/j.eururo.2018.10.056 10.1111/bju.15081 10.1080/10810730.2019.1617807 10.1590/S1677-5538.IBJU.2019.05.04 10.1016/j.euf.2019.07.004
Prostate Cancer and Prostatic Diseases; Xu AJ, Myrie A et. al.

Dec 3rd, 2021 - The quality of prostate cancer (PCa) content on Instagram is unknown. We examined 62 still-images and 64 video Instagram posts using #prostatecancer on 5/18/20. Results were assessed with validated tools. Most content focused on raising awareness ...

Prostate cancer risk stratification via non-destructive 3D pathology with deep learning...
https://doi.org/10.1158/0008-5472.CAN-21-2843
Cancer Research; Xie W, Reder NP et. al.

Dec 3rd, 2021 - Prostate cancer treatment planning is largely dependent upon examination of core-needle biopsies. The microscopic architecture of the prostate glands forms the basis for prognostic grading by pathologists. Interpretation of these convoluted 3D gla...

see more →

Guidelines  74 results

The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate...
https://doi.org/10.1016/j.euf.2021.09.008
European Urology Focus; Beyer K, MacLennan SJ et. al.

Oct 5th, 2021 - Patients are the stewards of their own care and hence their voice is important when designing and implementing research. Patients should be involved not only as participants in research that impacts their care, as the recipients of that care and a...

NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.
https://doi.org/10.6004/jnccn.2021.0008
Journal of the National Comprehensive Cancer Network : JN... Schaeffer E, Srinivas S et. al.

Feb 6th, 2021 - The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, and metastatic disease. Recommendations for disease monitoring and treatment of r...

Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: A...
https://doi.org/10.1200/JCO.20.03256
Journal of Clinical Oncology : Official Journal of the Am... Virgo KS, Rumble RB et. al.

Jan 27th, 2021 - Update all preceding ASCO guidelines on initial hormonal management of noncastrate advanced, recurrent, or metastatic prostate cancer. The Expert Panel based recommendations on a systematic literature review. Recommendations were approved by the E...

ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but...
https://doi.org/10.1016/j.prro.2020.10.002
Practical Radiation Oncology; Zietman AL,

Dec 15th, 2020 - ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but Changing Role for the Radiation Oncologist.|2020|Zietman AL, ,|radiotherapy,

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, ...
https://doi.org/10.1016/j.eururo.2020.09.042
European Urology; Mottet N, van den Bergh RCN et. al.

Nov 12th, 2020 - To present a summary of the 2020 version of the European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-Internatio...

see more →

Drugs  197 results see all →

Clinicaltrials.gov  1,640 results

A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT02608359

Dec 3rd, 2021 - This is a prospective (the participants are identified and then followed forward in time for the outcome of the study), multicenter (when more than one hospital or medical school team work on a medical research study), post-marketing surveillance ...

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT02123758

Dec 3rd, 2021 - This is a multicenter, open-label (participants will know the identity of study drug received) study in participants with Metastatic Castration-Resistant Prostate Cancer (mCRPC). The study is a single sequence design (ie, all participants will tak...

Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03646162

Dec 3rd, 2021 - This study is a multicenter, randomized, double-blind, placebo controlled, dose finding study of VERU-944 to treat hot flashes (vasomotor symptoms) in men with advanced prostate cancer on ADT. The study will have four arms with 30 subjects per arm...

Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT01040624

Dec 3rd, 2021 - The purpose of this study is to see what effects, good and/or bad, proton based radiation combined with low dose chemotherapy and hormonal therapy, has on patients and their cancer.

A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT00972309

Dec 3rd, 2021 - BACKGROUND: T-cell receptor alternate reading frame protein (TARP) is expressed by both normal and malignant prostate cancer tissue and is found in about 95% of prostate cancer specimens. TARP is immunogenic and hence is a target antigen for vacci...

see more →

News  4,413 results

Antibody-Drug Conjugates Take Center Stage in NSCLC
https://www.onclive.com/view/antibody-drug-conjugates-take-center-stage-in-nsclc

Nov 22nd, 2021 - Antibody-drug conjugates (ADCs) targeting TROP2, HER2, and, most recently, B7H3 have taken the field of non–small cell lung cancer (NSCLC) by storm, said Melissa Johnson, MD. She added that the TROP2-directed ADC, datopotamab deruxtecan, has the p...

Prostate cancer: Surgery lowers mortality risk in high-risk group
https://www.mdedge.com/fedprac/article/248747/prostate-cancer/prostate-cancer-surgery-lowers-mortality-risk-high-risk-group

Nov 15th, 2021 - Key clinical point: Radical prostatectomy vs external beam radiotherapy (EBRT) is associated with significant improvement in cancer-specific mortality in patients with National Comprehensive Cancer Network (NCCN) high-risk and Johns Hopkins Univer.

Increase in PSA testing after 2017 USPSTF recommendations
https://www.mdedge.com/fedprac/article/248743/prostate-cancer/increase-psa-testing-after-2017-uspstf-recommendations

Nov 15th, 2021 - Key clinical point: Prostrate-specific antigen (PSA) testing increased after the 2017 United States Preventive Services Task Force (USPSTF) draft statement for prostate cancer screening. Major finding: A relative increase of 12.

Prostate cancer: Salvage LDR brachytherapy after EBRT shows good response
https://www.mdedge.com/fedprac/article/248737/prostate-cancer/prostate-cancer-salvage-ldr-brachytherapy-after-ebrt-shows

Nov 15th, 2021 - Key clinical point: Salvage low-dose-rate (LDR) prostate brachytherapy shows good survival in patients with low-/intermediate-risk prostate cancer who had local failure after external beam radiotherapy (EBRT). Major finding: The median follow-up w.

Institutional Perspectives in Cancer- Precision Medicine: Chaired by Jyoti Patel, MD
https://www.onclive.com/view/institutional-perspectives-in-cancer--precision-medicine-chaired-by-jyoti-patel-md

Nov 15th, 2021 - Institutional Perspectives in Cancer- Precision Medicine: Chaired by Jyoti Patel, MD The live filming of this virtual event in our IPC series is now on-demand. OncLive is proud to present the State of the Science Summits and a new virtual even...

see more →

Patient Education  62 results see all →